Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario P Colombo

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Cell Reports|February 16, 2024
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansionBarbara Bassani, Giorgia Simonetti, Valeria Cancila, et al.
Cancer Research|April 9, 2020
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCsChiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
The Journal of Clinical Investigation|July 17, 2025
Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark ZoneValeria Cancila, Giorgio Bertolazzi, Allison Sy Chan, et al.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Cell Reports|February 16, 2024
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansionBarbara Bassani, Giorgia Simonetti, Valeria Cancila, et al.
Cancer Research|April 9, 2020
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCsChiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
The Journal of Clinical Investigation|July 17, 2025
Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark ZoneValeria Cancila, Giorgio Bertolazzi, Allison Sy Chan, et al.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 15